
Altos Labs develops cellular-rejuvenation therapies through partial epigenetic reprogramming, aiming to reverse disease by restoring cell health and resilience.
Former members 1
Based on public sources. If accuracy is important, verify details using the links or references.
For corrections, updates, or requests to remove information, contact us.
Reviewed August 15, 2026 · Checked for accuracy and new information.



